Two Sigma Investments’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Hold
133,325
﹤0.01% 3013
2025
Q4
$1.39M Hold
133,325
﹤0.01% 2708
2025
Q3
$1.38M Buy
+133,325
New +$1.38M ﹤0.01% 2372

Other funds holding TDAC

Two Sigma Investments's TDAC Position: Q1 2026 in Review

Two Sigma Investments held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 133,325 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3013.

Two Sigma Investments first reported a position in TDAC in Q3 2025 and has held it in 3 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Two Sigma Investments held 133,325 shares of Translational Development Acquisition Corp worth $1.41M as of Q1 2026.
  • Two Sigma Investments left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3013 holding.
  • Two Sigma Investments first reported a position in Translational Development Acquisition Corp in Q3 2025 and has held it in 3 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.